Business Context and Reporting Period
This Form 8-K filing by cbdMD, Inc. reports corporate actions effective as of May 6, 2025. The company, incorporated in North Carolina, announced two material capital structure changes approved by shareholders at the annual meeting on April 10, 2025: the mandatory conversion of preferred stock and a reverse stock split of common stock.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on equity restructuring events.
Material Changes Versus Prior Period
- Preferred Stock Conversion: All 5,000,000 outstanding shares of 8% Series A Cumulative Convertible Preferred Stock automatically converted into 65,000,000 shares of Common Stock. This conversion included all accumulated and unpaid dividends. Dividend accruals ceased, and the preferred stock ceased trading on the NYSE American.
- Reverse Stock Split: A one-for-eight (1-for-8) reverse stock split of Common Stock was effected immediately following the preferred conversion. Every 8 shares of Common Stock (including those issued from the conversion) were converted into 1 share.
- Trading Adjustments: The Common Stock began trading on a reverse split-adjusted basis on May 7, 2025. The CUSIP number changed to 12482W 409.
- Fractional Shares: No fractional shares were issued; shareholders entitled to a fractional share received one whole share instead.
- Derivative Adjustments: All outstanding stock options and warrants were adjusted to reflect the reverse split.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors beyond the structural changes described. The primary contingency noted is the adjustment of shareholder holdings and derivative instruments to align with the new capital structure.
Investor Verification Checklist
- Verify the adjusted share count and ownership percentage post-conversion and post-split.
- Confirm the new CUSIP number (12482W 409) for Common Stock trading.
- Review the adjustment terms for any held stock options or warrants.
- Check the cessation of dividend accruals on the former Preferred Stock.
- Confirm the trading status of the Common Stock on the NYSE American starting May 7, 2025.